VLTR 85x
Alternative Names: VLTR-85xLatest Information Update: 18 Jul 2023
At a glance
- Originator Valitor
- Class Drug conjugates; Eye disorder therapies
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Research Diabetic macular oedema; Wet age-related macular degeneration
Most Recent Events
- 18 Jul 2023 Early research in wet age-related macular degeneration in USA (Valitor pipeline, July 2023)